Lisa O’Rourke
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Gastroenterology top 5%
Papers in
- Oncology 18
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 10
-
- Advanced Breast Cancer Therapies 14
- Co-authors
- J. Maltzman (17 shared papers)Stephen Johnston (10 shared papers)Peter R. Shepherd (4 shared papers)Allison Florance (11 shared papers)Michael F. Press (4 shared papers)Henry Gómez (5 shared papers)John Pippen (6 shared papers)Xavier Pivot (8 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer Research (6 papers)The Oncologist (3 papers)Clinical Cancer Research (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Lisa O’Rourke
30 papers receiving 1.5k citations
Lisa O’Rourke's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 805
- Gastroenterology 96
- Cancer Research 231
- Endocrine and Autonomic Systems 94
- Pulmonary and Respiratory Medicine 357
Countries citing papers authored by Lisa O’Rourke
This map shows the geographic impact of Lisa O’Rourke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa O’Rourke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa O’Rourke more than expected).
Fields of papers citing papers by Lisa O’Rourke
This network shows the impact of papers produced by Lisa O’Rourke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa O’Rourke. The network helps show where Lisa O’Rourke may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa O’Rourke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer Hit paper breakdown → | 2009 | 768 |
| 2 | 2010 | 158 | |
| 3 | 2013 | 110 | |
| 4 | 2002 | 90 | |
| 5 | 2001 | 80 | |
| 6 | 2002 | 56 | |
| 7 | 2009 | 49 | |
| 8 | 2019 | 43 | |
| 9 | 2003 | 25 | |
| 10 | 2010 | 24 | |
| 11 | 2013 | 20 | |
| 12 | 2010 | 13 | |
| 13 | 2011 | 7 | |
| 14 | 2009 | 6 | |
| 15 | 2017 | 6 | |
| 16 | 2009 | 5 | |
| 17 | 2009 | 4 | |
| 18 | 2009 | 4 | |
| 19 | 2009 | 4 | |
| 20 | 2024 | 4 |
About Lisa O’Rourke
Lisa O’Rourke is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Endocrine and Autonomic Systems and Genetics, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (14 papers), Cancer Treatment and Pharmacology (13 papers), HER2/EGFR in Cancer Research (10 papers), Multiple Myeloma Research and Treatments (6 papers), Regulation of Appetite and Obesity (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Oncology (805 citations), Gastroenterology (96 citations), Cancer Research (231 citations), Endocrine and Autonomic Systems (94 citations) and Pulmonary and Respiratory Medicine (357 citations). Lisa O’Rourke has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include J. Maltzman, Stephen Johnston, Peter R. Shepherd, Allison Florance, Michael F. Press, Henry Gómez, John Pippen, Xavier Pivot, Mark D. Pegram and Alexey Manikhas. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Oncologist, Clinical Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.